Article

Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors

Department of Pathology, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA, USA.
Modern Pathology (Impact Factor: 6.36). 07/2001; 14(6):577-80. DOI: 10.1038/modpathol.3880353
Source: PubMed

ABSTRACT Orthotopic liver transplantation, by eliminating the major site of amyloidogenic protein synthesis, is currently the only definitive treatment of most hereditary amyloidoses. Because of the minimal parenchymal involvement, the explanted livers from familial amyloidotic polyneuropathy (FAP) patients have been transplanted into non-FAP patients in a "domino" fashion. The aim of this study was to evaluate the extent of amyloid deposits in explanted livers from two patients with apolipoprotein A-I amyloidosis, with the Arg26 mutation, to determine their suitability as domino donors. A detailed histologic review of the explanted livers from two patients was performed and assessed for the extent of amyloid deposition by routine and Congo red stains. Both patients had identical histopathologic features. The liver parenchymal involvement was strikingly severe. Large patches of amyloid separated hepatic cords, with accentuation around the central veins. All portal triads were consistently and markedly involved with amorphous eosinophilic deposits within the connective tissue compressing the bile ducts and vascular structures. Hilar vessels had patchy deposits. No involvement of hilar nerve branches was seen. The hepatic parenchyma is extensively involved in hereditary Apolipoprotein A-I amyloidosis, with the Arg26 mutation. These livers, removed at orthotopic liver transplantation, are not suitable for domino donation.

0 Followers
 · 
64 Views
 · 
0 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The authors describe a speaker-independent voice activated automated telephone call routing system that allows callers to ask for a person by name, and then be transferred to that person's extension. The system utilizes the BBN HARK Recognizer, a commercially available speech recognition system which runs in real-time on a UNIX workstation and does not require a digital signal processing (DSP) microprocessor for performing front-end signal processing. The system has been operational since August 1992. It deals with over 500 calls daily and many users have come to rely on it as an easy to use and reliable tool. Currently, it is configured to recognize the 1847 names representing all BBN personnel based in Cambridge, Massachusetts. New names are easily added to the recognition system by simply entering the phonetic transcription of the names to the vocabulary
    Artificial Intelligence for Applications, 1993. Proceedings., Ninth Conference on; 04/1993
  • [Show abstract] [Hide abstract]
    ABSTRACT: Amyloid is defined as a proteinaceous tissue deposit that shows a typical green birefringence in polarized light after staining with Congo red, the presence of non-branching linear fibrils of indefinite length with a mean diameter of 10 nm, and a distinct X-ray diffraction pattern consistent with Pauling's model of a cross beta-fibril. Amyloid may deposit locally or may present as a systemic disease. The origin of amyloid is diverse: 25 different fibril proteins have been described so far. The precursor proteins differ from each other in their primary structures and functions. The only common denominator is the propensity to form anti-parallel cross beta-fibrils under certain circumstances. Early diagnosis of amyloid is still a major challenge in surgical pathology. Histological proof can be obtained using Congo-red staining and polarization microscopy. However, small deposits may be difficult to discern, and sensitivity can be improved using fluorescence microscopy. Classification of amyloid is mandatory, since amyloid is treatable and different treatment regimens are applied to different amyloid diseases. This review focuses on the epidemiology, clinical features, pathology and diagnosis of amyloid in surgical pathology.
    Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 08/2003; 443(1):3-16. DOI:10.1007/s00428-003-0834-y · 2.56 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Amyloidosis results from local or systemic extracellular deposition of insoluble protein fibrils and is associated with certain rare mutations in APOA1 encoding apolipoprotein (apo) A-I. In a patient with renal-predominant amyloidosis with neuropathy, we found the APOA1 G26R mutation. While the spectrum of APOA1 mutations provides no particular mechanistic insights, molecular diagnosis may still be important due to clinical differences between amyloidosis resulting from mutation in APOA1 vs. other genes.
    Clinical Biochemistry 12/2003; 36(8):641-5. DOI:10.1016/S0009-9120(03)00110-3 · 2.28 Impact Factor
Show more

Preview

Download
0 Downloads
Available from